| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.069 | 0.04 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.04 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | -0.071 | 0.04 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.04 |
| mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | -0.06 | 0.04 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.59 | 0.04 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | -0.082 | 0.04 |
| mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.04 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.04 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.17 | 0.05 |